Cypress Bioscience Inc: Highlights

Financial data in U.S. dollars

Financial Highlights
Sales 15.59 Mil
Income -29.12 Mil
Net Profit Margin -186.78%
Return on Equity -18.55%
Debt/Equity Ratio 0.00
Revenue/Share 0.41
Earnings/Share -0.77
Book Value/Share 3.85
Dividend Rate 0.00
Payout Ratio NA
Revenue - Quarterly Results (in Millions)
 FY (12/09)FY (12/08)FY (12/07)
1st Qtr7.914.21.0
2nd Qtr5.81.05.9
3rd QtrNA1.01.0
4th QtrNA0.96.1
Total13.717.213.9
Earnings Per Share - Quarterly Results
 FY (12/09)FY (12/08)FY (12/07)
1st Qtr-$0.24-$0.08-$0.04
2nd Qtr-$0.23-$0.11$0.07
3rd QtrNA-$0.11-$0.02
4th QtrNA-$0.19$0.08
Total-$0.47-$0.49$0.09
Qtr. over Qtr. EPS Growth Rate
FY (12/09)FY (12/08)FY (12/07)
1st Qtr-26%NA---
2nd Qtr4%-38%NA
3rd QtrNA0%NA
4th QtrNA-73%NA
Yr. over Yr. EPS Growth Rate
FY (12/09)FY (12/08)
1st Qtr-200%-100%
2nd Qtr-109%NA
3rd QtrNA-450%
4th QtrNANA

advertisement